Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
ON Semiconductor
ON
$30.7B
| $139M | 0.06% |
1,686,964
+134,826
| +9% | +$10.2M |
|
202
CALL
Cummins
CMI
$83.6B
| $139M | 0.06% |
+580,000
| New | +$142M |
|
203
Vertex Pharmaceuticals
VRTX
$123B
| $137M | 0.06% |
436,062
-175,725
| -29% | -$52.7M |
|
204
NextEra Energy
NEE
$185B
| $137M | 0.06% |
1,771,469
-1,451,729
| -45% | -$112M |
|
205
Target
TGT
$66.3B
| $135M | 0.06% |
817,281
-420,033
| -34% | -$69.1M |
|
206
Energy Transfer Partners
ET
$69.5B
| $134M | 0.06% |
10,763,804
-6,316,334
| -37% | -$79.8M |
|
207
PUT
Palo Alto Networks
PANW
$256B
| $133M | 0.06% |
1,327,550
-1,029,850
| -44% | -$87.3M |
|
208
Abbott
ABT
$187B
| $132M | 0.06% |
1,306,397
-1,266,971
| -49% | -$134M |
|
209
Medtronic
MDT
$112B
| $132M | 0.06% |
1,632,730
-4,186,727
| -72% | -$341M |
|
210
Altria Group
MO
$125B
| $131M | 0.06% |
2,927,146
-1,096,652
| -27% | -$50.4M |
|
211
Alcon
ALC
$34B
| $131M | 0.06% |
1,851,500
+1,031,276
| +126% | +$73.4M |
|
212
NRG Energy
NRG
$26.2B
| $130M | 0.06% |
3,793,337
+2,858,334
| +306% | +$94.7M |
|
|
PPL
213
PPL Corp
PPL
$26.9B
| $129M | 0.06% |
4,659,478
+3,031,843
| +186% | +$85.9M |
|
|
SCHW
214
Charles Schwab
SCHW
$182B
| $128M | 0.06% |
2,447,774
-691,771
| -22% | -$50.7M |
|
215
CALL
Rivian
RIVN
$23.6B
| $128M | 0.06% |
8,250,400
+3,717,700
| +82% | +$62.8M |
|
216
Biogen
BIIB
$30.9B
| $127M | 0.06% |
457,843
-164,885
| -26% | -$45.6M |
|
217
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
| $127M | 0.06% |
2,899,500
+134,500
| +5% | +$7.63M |
|
|
ATVI
218
DELISTED
Activision Blizzard
ATVI
| $127M | 0.06% |
1,481,763
-2,446,246
| -62% | -$190M |
|
219
American International
AIG
$42.5B
| $127M | 0.06% |
2,512,021
+577,954
| +30% | +$33.8M |
|
220
PUT
JPMorgan Chase
JPM
$916B
| $126M | 0.06% |
967,400
+442,300
| +84% | +$60.6M |
|
221
Intuitive Surgical
ISRG
$127B
| $124M | 0.06% |
486,595
-399,061
| -45% | -$98.3M |
|
222
CSX Corp
CSX
$94B
| $123M | 0.06% |
4,117,735
-4,783,999
| -54% | -$147M |
|
223
RTX Corp
RTX
$290B
| $123M | 0.06% |
1,255,579
-1,922,977
| -60% | -$189M |
|
224
CME Group
CME
$95.4B
| $123M | 0.06% |
641,188
-231,097
| -26% | -$41.8M |
|
225
CALL
Pinduoduo
PDD
$126B
| $122M | 0.06% |
1,610,000
+112,600
| +8% | +$10.2M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.